The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast period. Increasing prevalence of immunodeficiency disease, rising adoption of Intravenous immunoglobulin treatment and rapid technological advancement in therapy are key factors driving market revenue growth.
The study on the Global...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek